Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.2 USD | 0.00% | +10.26% | +42.15% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.15% | 584M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.03% | 33.03B | |
+55.32% | 24.68B | |
-16.26% | 15.12B | |
-8.92% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Stephens Adjusts Avid Bioservices Price Target to $20 From $24, Maintains Overweight Rating